Your shopping cart is currently empty

PG 106 acetate is an effective and selective antagonist of the human melanocortin 3 (hMC3) receptor with an IC50 of 210 nM. PG 106 acetate has no activity with the hMC5 receptor and hMC4 receptors with an EC50 of 9900 nM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $74 | - | In Stock | |
| 5 mg | $251 | - | In Stock | |
| 10 mg | $358 | - | In Stock | |
| 25 mg | $541 | - | In Stock | |
| 50 mg | $721 | - | In Stock | |
| 100 mg | $987 | - | In Stock | |
| 200 mg | $1,310 | - | In Stock |
| Description | PG 106 acetate is an effective and selective antagonist of the human melanocortin 3 (hMC3) receptor with an IC50 of 210 nM. PG 106 acetate has no activity with the hMC5 receptor and hMC4 receptors with an EC50 of 9900 nM. |
| Targets&IC50 | MC3R (human):210 nM |
| Synonyms | PG 106 acetate(944111-22-2 Free base) |
| Molecular Weight | 1068.23 |
| Formula | C53H73N13O11 |
| Smiles | CCCCC(NC(C)=O)C(N[C@H]1CC(NCCCC[C@@H](C(N)=O)NC([C@H](CC2=CNC3=CC=CC=C32)NC([C@H](CCC/N=C(N)\N)NC([C@@H](CC4=CC5=CC=CC=C5C=C4)NC(CCNC1=O)=O)=O)=O)=O)=O)=O.CC(O)=O |
| Sequence | Ac-DL-Nle-Asp(1)-bAla-D-2Nal-Arg-Trp-Lys(1)-NH2 |
| Sequence Short | {Nle}-D-{Bal}-{D-Nal}-RWK (Lactam bridge:Asp2-Lys7) |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.